The glycine 90 to aspartate alteration in the Aβ subunit of PP2A (PPP2R1B) associates with breast cancer and causes a deficit in protein function

Mutations of the PPP2R1B gene, which encodes the Aβ scaffolding subunit of serine/threonine protein phosphatase 2A (PP2A), have been identified in several types of cancer including lung and breast carcinoma. One of these mutations results in an alteration of glycine 90 to aspartic acid (G90D), which has been found in both tumor and genomic DNA, raising the possibility that it is associated with an increased risk for cancer. A novel microarray‐based technology was used to screen for this single‐nucleotide polymorphism in 387 cancer patients and 329 control individuals. These data were used for case–control and family‐based comparisons in order to study the association of this polymorphism with susceptibility to lung carcinoma, breast carcinoma, and acute lymphoblastic leukemia. The frequency of the G90D polymorphism in breast cancer patients was significantly higher in cases (3%) than in controls (0.3%). The wild‐type Aβ subunit interacted with the B56γ (PPP2R5C), PR72 (PPP2R3A), and PR48 subunits of PP2A but did not interact with the B55α (PPP2R2A), B56α (PPP2R5A), or B56β (PPP2R5B) regulatory subunits in an in vitro binding assay. The G90D alteration inhibited the interaction of Aβ with the B56γ subunit but had no effect on binding to the PR72 subunit. These results provide evidence that the G90D alteration of the Aβ subunit of PP2A is associated with a low frequency of breast carcinoma and that the role of this alteration in transformation is likely to involve decreased interaction with the B56γ regulatory subunit. © 2005 Wiley‐Liss, Inc.

[1]  Alicia Samuels,et al.  Cancer Statistics, 2003 , 2003, CA: a cancer journal for clinicians.

[2]  D. Virshup,et al.  Identification of a New Family of Protein Phosphatase 2A Regulatory Subunits (*) , 1995, The Journal of Biological Chemistry.

[3]  J. Minna,et al.  Alterations of the PPP2R1B gene in human lung and colon cancer. , 1998, Science.

[4]  G. Hampton,et al.  Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. , 1995, Cancer research.

[5]  G. Russo,et al.  Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms. , 2000, Oncogene.

[6]  Zhen Yan,et al.  PR48, a Novel Regulatory Subunit of Protein Phosphatase 2A, Interacts with Cdc6 and Modulates DNA Replication in Human Cells , 2000, Molecular and Cellular Biology.

[7]  G. Evans,et al.  Identification of a 6-cM minimal deletion at 11q23.1-23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer. , 2000, Cancer research.

[8]  C. Bakkenist,et al.  Allelic deletions at chromosome 11q22-q23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers , 1997, Oncogene.

[9]  M. Mumby,et al.  Comparison of heterotrimeric protein phosphatase 2A containing different B subunits. , 1994, The Journal of biological chemistry.

[10]  I. Campbell,et al.  Absence of PPP2R1B gene alterations in primary ovarian cancers , 1999, Oncogene.

[11]  Brian A. Hemmings,et al.  The Structure of the Protein Phosphatase 2A PR65/A Subunit Reveals the Conformation of Its 15 Tandemly Repeated HEAT Motifs , 1999, Cell.

[12]  M. Beckmann,et al.  Loss of heterozygosity at 11q23.1 and survival in breast cancer: Results of a large European study , 1999, Genes, chromosomes & cancer.

[13]  Carlos Cordon-Cardo,et al.  Pten is essential for embryonic development and tumour suppression , 1998, Nature Genetics.

[14]  J. Minna,et al.  Refined mapping of two regions of loss of heterozygosity on chromosome band 11q23 in lung cancer , 1999, Genes, chromosomes & cancer.

[15]  G. Russo,et al.  Low frequency of alterations of the α (PPP2R1A) and β (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms , 2000, Oncogene.

[16]  M. Schrappe,et al.  Identification of three distinct regions of deletion on the long arm of chromosome 11 in childhood acute lymphoblastic leukemia , 1999, Oncogene.

[17]  Y. Takagi,et al.  Alterations of the PPP2R1B gene located at 11q23 in human colorectal cancers , 2000, Gut.

[18]  Huong T. T. Pham,et al.  Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the Aα subunit gene , 2001, Oncogene.

[19]  G. Walter,et al.  Binding Specificity of Protein Phosphatase 2A Core Enzyme for Regulatory B Subunits and T Antigens , 1999, Journal of Virology.

[20]  J. Rossant,et al.  The Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the Mouse , 1996, Cell.

[21]  C. Croce,et al.  Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: identification of three independent regions. , 1995, Cancer research.

[22]  Huong T. T. Pham,et al.  Characterization of the Aalpha and Abeta subunit isoforms of protein phosphatase 2A: differences in expression, subunit interaction, and evolution. , 2003, The Biochemical journal.

[23]  P Bork,et al.  Comparison of ARM and HEAT protein repeats. , 2001, Journal of molecular biology.

[24]  M. Mumby,et al.  Protein serine/threonine phosphatases and cell transformation. , 1993, Biochimica et biophysica acta.

[25]  W. Hahn,et al.  Identification of specific PP2A complexes involved in human cell transformation. , 2004, Cancer cell.

[26]  D. Gerhard,et al.  Fine mapping and evaluation of candidate genes for cervical cancer on 11q23 , 2005, Genes, chromosomes & cancer.

[27]  T. Goi,et al.  PPP2R1B gene alterations inhibit interaction of PP2A-Abeta and PP2A-C proteins in colorectal cancers. , 2004, Oncology reports.

[28]  M. Mumby,et al.  Molecular model of the A subunit of protein phosphatase 2A: interaction with other subunits and tumor antigens , 1994, Journal of virology.

[29]  D. Birnbaum,et al.  Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCA1 gene regions , 1997, Oncogene.

[30]  G. Calin,et al.  Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region , 1999, Oncogene.

[31]  M. Mumby,et al.  Identification of a Novel Protein Phosphatase 2A Regulatory Subunit Highly Expressed in Muscle (*) , 1996, The Journal of Biological Chemistry.

[32]  V. Janssens,et al.  Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. , 2001, The Biochemical journal.

[33]  C. Croce,et al.  Molecular cloning and characterization of LOH11CR2A, a new gene within a refined minimal region of LOH at 11q23. , 1997, Genomics.

[34]  Huong T. T. Pham,et al.  Alterations in protein phosphatase 2A subunit interaction in human carcinomas of the lung and colon with mutations in the Aβ subunit gene , 2001, Oncogene.

[35]  J. Hofsteenge,et al.  Structure and expression of a 72-kDa regulatory subunit of protein phosphatase 2A. Evidence for different size forms produced by alternative splicing. , 1993, The Journal of biological chemistry.

[36]  K. Franssila,et al.  Alterations in the suppressor gene PPP2R1B in parathyroid hyperplasias and adenomas. , 2002, Cancer genetics and cytogenetics.